Welcome to our dedicated page for Rocket Doctor AI news (Ticker: AIRDF), a resource for investors and traders seeking the latest updates and insights on Rocket Doctor AI stock.
Rocket Doctor AI Inc. (AIRDF) is a healthcare technology company that reports on developments at the intersection of artificial intelligence and digital health. Company news frequently highlights its physician-built Global Library of Medicine (GLM), an AI-powered clinical decision support system, and the activities of its wholly owned digital health platform and marketplace, Rocket Doctor Inc.
Investors and observers following AIRDF news can read about partnerships, technology rollouts, and corporate milestones. Recent announcements have covered collaborations with organizations such as the CAN Health Network and Health Cities in Alberta to pilot an AI-powered Clinical Decision Support System, as well as a strategic partnership between Rocket Doctor Inc. and Toronto Metropolitan University to expand clinical education opportunities on a digital health platform. The company also publishes updates on its U.S. expansion, including payer credentialing and leadership appointments to support growth across multiple states.
Rocket Doctor AI’s news flow includes information on product development, such as enhancements to its GLM, Starship EMR, RD Connect, and RD Health Voyager tools, along with initiatives like pharmacy-based virtual care programs and emergency department diversion efforts. Corporate and capital markets updates, including private placements, analyst coverage arrangements, and grants of restricted share units and stock options, are also disclosed through news releases.
This news page aggregates these company-issued updates in one place, allowing readers to follow how Rocket Doctor AI is applying AI-powered clinical decision support, virtual care technology, and partnerships with healthcare and academic institutions. For those tracking AIRDF, the news feed provides context on how the company describes its strategy, technology evolution, and market initiatives over time.
Rocket Doctor (OTC: AIRDF) appointed Dr. Anikia Nelson as Director of Product and Bilal Malik as Director of Engineering to advance its digital health platform and AI capabilities. The company granted 143,388 RSUs and 5,738 options at C$0.70 exercise price, each with three-year terms and vesting provisions.
Appointments target product roadmap, scalability, interoperability, HIPAA-compliant infrastructure, and growth across North America.
Rocket Doctor AI (OTC:AIRDF) announced a new in-network agreement with a major California health plan, adding approximately 330,000 Medicare Advantage members and more than 1.7 million commercial members across California, expanding in-network access by ~2.03 million members.
Eligible members gain access to Rocket Doctor’s board-certified physicians for primary care, chronic disease management, preventive services and coordinated follow-up via its digital health platform, subject to credentialing and plan eligibility.
Rocket Doctor AI (OTC: AIRDF) reported that holders exercised a total of 3,414,896 common share purchase warrants at $0.60, generating aggregate gross proceeds of approximately CAD$2,048,938 through March 13, 2026.
Of those, 2,054,224 warrants were exercised in the prior three months, producing about CAD$1,232,535. The company said proceeds will be used for working capital and general corporate purposes as it pursues North American AI healthcare expansion and 2026 U.S. growth plans.
Rocket Doctor AI (OTC: AIRDF) announced an in-network agreement with a major New York insurer adding approximately 20,000 Medicare Advantage and D-SNP members, effective April 1, 2026. This builds on a March 3, 2026 expansion of ~2.4 million members and brings total in-network reach to over 15 million covered lives nationwide. The agreement enables eligible New York members to access board-certified physicians via Rocket Doctor’s digital health platform for primary care, chronic disease management, preventive services, and coordinated follow-up, pending credentialing and plan eligibility.
Rocket Doctor (OTC:AIRDF) signed an in-network agreement with a major New York insurer covering more than 2.4 million members, expanding access across Medicaid Managed Care, HARP, Medicare Advantage/D-SNP, Managed Long-Term Care, and individual plans.
The deal increases Rocket Doctor’s total in-network reach to over 15 million covered lives across key U.S. markets, reinforcing rapid payer network expansion and broader access to digital medical and behavioral health services in New York.
Rocket Doctor AI (OTC:AIRDF) and Lethbridge County launched a partnership on Feb 24, 2026 to expand Alberta Health–covered virtual primary and urgent care with no user fees. The agreement launches today, automatically renewing for subsequent two-year periods on identical terms.
The county-specific service gives residents secure virtual access to licensed Alberta physicians for urgent care, chronic condition management, primary care and mental health, and aims to address rural physician shortages.
Rocket Doctor reported serving 16,417 patients in Q3 2025, up from 9,090 in Q3 2024 (an 81% YoY increase).
Rocket Doctor AI (OTC: AIRDF) engaged Danayi Capital for a two-month digital marketing contract starting Feb 9, 2026 for an up-front fee of USD 125,000. Danayi will run online advertising via wallstreetlogic.com and holds no current interest in the company.
The company also granted 33,353 stock options exercisable at $0.77 for three years and 205,065 restricted share units valid for three years; both awards vest over one year and are issued under the company’s share compensation plans.
Rocket Doctor (OTC:AIRDF) signed an agreement with a major U.S. commercial insurer to add approximately 175,000 eligible members in California to its in-network physician marketplace. The addition increases Rocket Doctor’s total in-network reach to well over 13 million covered lives across key U.S. markets (primarily California and New York). The contract covers employer-sponsored health plans in California and positions the company to strengthen its payer mix, support clinician-led access to care, and pursue sustained U.S. revenue growth while complying with applicable California benefit and regulatory requirements.
Rocket Doctor AI (OTC: AIRDF) announced grants of equity awards to consultants on January 12, 2026. The company granted an aggregate 75,000 stock options exercisable at $0.74 per share for a three‑year term and 212,148 restricted share units (RSUs) with a three‑year term. All awards vest over one year and are issued under the company’s share compensation plans.
Rocket Doctor AI (OTC: AIRDF) closed its acquisition of Alea Health on Jan 8, 2026, under a definitive share purchase agreement dated Nov 19, 2025, as amended Dec 31, 2025.
The consideration included a US $15,000 acquisition deposit previously paid in cash, issuance of 285,712 common shares at a deemed CAD $0.70 per share, and assumption of a US $180,000 SAFE note to be paid in equal monthly installments of US $22,500, with the first installment paid at closing.
Consideration shares were issued under prospectus exemptions, are subject to a statutory hold period of four months and one day, and a 28-month escrow schedule releasing 20% every four months beginning on the first anniversary. No finder’s fees were paid and no long-term liabilities were assumed other than the SAFE note.